CAS RN: 1197294-66-8
tert-butyl 4-(4-broMothiazol-2-yl)piperazine-1-carboxylate
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 100g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1197294-66-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
100g
≥95%
0
Out of Stock
Shanghai
Inquiry
1197294-66-8 / tert-butyl 4-(4-bromo-1,3-thiazol-2-yl)piperazine-1-carboxylate
tert-butyl 4-(4-bromothiazol-2-yl)piperazine-1-carboxylate | tert-butyl 4-(4-bromo-1,3-thiazol-2-yl)piperazine-1-carboxylate | MFCD13193152
Standard CAS: 1197294-66-8
Multi CAS: No
Basic Information
copy
CAS
1197294-66-8 copy
Multi CAS
No copy
Molecular Formula
C12H18BrN3O2S copy
Molecular Weight
348.260000 copy
Exact Mass
347.030310 copy
SMILES
CC(C)(C)OC(=O)N1CCN(CC1)C2=NC(=CS2)Br copy
InChI
InChI=1S/C12H18BrN3O2S/c1-12(2,3)18-11(17)16-6-4-15(5-7-16)10-14-9(13)8-19-10/h8H,4-7H2,1-3H3 copy
InChIKey
PJTYRYGVZASDJM-UHFFFAOYSA-N copy
Synonyms
tert-butyl 4-(4-bromothiazol-2-yl)piperazine-1-carboxylate
tert-butyl 4-(4-bromo-1,3-thiazol-2-yl)piperazine-1-carboxylate
MFCD13193152
2-(4-BOC-Piperazino)-4-bromothiazole
1-Piperazinecarboxylic acid, 4-(4-bromo-2-thiazolyl)-, 1,1-dimethylethyl ester copy
Computed Properties
copy
Structural Parameters
Heavy atom count
19 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.67 copy
Rotatable bonds
1 copy
H-bond acceptors
5 copy
Molar refractivity
79.83 copy
TPSA
45.67 copy
LogP / Solubility
WLOGP
2.96 copy
MLOGP
2.62 copy
XLogP3
3.1 copy
Consensus LogP
2.89 copy
Log S (ESOL)
-3.99 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.55 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.5 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.74 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
Pictogram(s)
Acute Toxic copy
Signal
Danger copy
GHS Hazard Statements
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] copy
Precautionary Statement Codes
P264, P270, P301+P316, P321, P330, P405, and P501 copy